Teva Pharmaceutical Industries Limited (
) will begin trading ex-dividend on May 16, 2014. A cash dividend
payment of $0.347 per share is scheduled to be paid on June 02,
2014. Shareholders who purchased TEVA stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 2.06% increase over the prior quarter. At the current
stock price of $50.53, the dividend yield is 2.75%.
The previous trading day's last sale of TEVA was $50.53,
representing a -7.62% decrease from the 52 week high of $54.70 and
a 39.35% increase over the 52 week low of $36.26.
TEVA is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Novartis AG (
). TEVA's current earnings per share, an indicator of a company's
profitability, is $1.63. Zacks Investment Research reports TEVA's
forecasted earnings growth in 2014 as -5.39%, compared to an
industry average of 14.5%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to TEVA through an Exchange
Traded Fund [ETF]?
The following ETF(s) have TEVA as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- iShares MSCI Israel Capped Investable Market Index Fund (
- iShares MSCI ACWI ex US Health Care Sector Index Fund
- First Trust Value Line Dividend Index Fund (
- Madrona International ETF (
The top-performing ETF of this group is PPH with an increase of
14.21% over the last 100 days. It also has the highest percent
weighting of TEVA at 4.83%.